Apollo Ventures

What is Apollo Ventures?

Apollo Ventures is a transatlantic early stage Venture Capital (VC) firm focused on the healthcare sector, specifically targeting age-related diseases and the process of aging itself. With operations in Europe and the U.S., their approach combines traditional funding with venture building to create and invest in transformative healthcare companies.

Apollo Ventures is known for their involvement in seed stage investments, reflecting their commitment to fostering the development of ground-breaking biotechnology for a healthier, extended lifespan, and lessening healthcare expenses.

They function as an active partner in their investments, leveraging extensive scientific and operational expertise to build top teams and minimize risks through conducting 'killer experiments.' They focus on acquiring founder shares at nominal values, which provides significant potential upsides for their investors.

Apollo's strategy also entails access to capital and strong syndicates. The firm plays a crucial role in the early stages of company growth, offering guidance on research and development, clinical trial and indication selection strategies. They have a successful track record dating back to 2017.

Their network and deep domain knowledge have rendered them a trusted partner in the industry, known for accelerating the progress of the companies they invest in and being instrumental in follow-on investment rounds. Apollo Ventures' portfolio includes companies such as Booster Therapeutics, HAYA Therapeutics, Ochre Bio, and Aeovian Pharmaceuticals, showcasing active venture creation and investment in best-in-class companies. They are headquartered in the UK, with offices in Berlin, Luxembourg, and Boston, indicating a strong presence across key innovation hubs.